As part of a class of drugs called dopamine agonists, Neupro® (rotigotine) transdermal patches are applied on the skin once daily to treat symptoms of Parkinson's disease or restless legs syndrome (RLS). In some cases, you may need to apply more than one patch to achieve the prescribed dosage.
Neupro patches work by affecting certain areas of the brain, which helps to stimulate dopamine receptors. It is believed that many of the symptoms of Parkinson's disease are caused by a dopamine deficiency, which is caused by a loss of dopamine-producing cells in certain parts of the brain.
While most people tolerate the medicine well, side effects can occur and may include drowsiness, nausea, and vomiting.
(For more information on these transdermal patches, click Neupro. This comprehensive overview includes details on dosing instructions, what to discuss with your healthcare provider, and more. It also discusses safety precautions to be aware of before beginning treatment.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed August 14, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click